Renchi Yang Selected Research

COVID-19

11/2020

Management of haemophilia patients in the COVID-19 pandemic: Experience in Wuhan and Tianjin, two differently affected cities in China.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Renchi Yang Research Topics

Disease

74	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2022 - 05/2004
25	Hemorrhage 11/2022 - 01/2008
24	Hemophilia A (Haemophilia) 11/2022 - 09/2010
16	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 08/2006
5	Thrombocytopenia (Thrombopenia) 01/2022 - 03/2008
5	Neoplasms (Cancer) 03/2011 - 04/2006
4	Genetic Predisposition to Disease (Genetic Predisposition) 10/2021 - 09/2007
4	Thrombosis (Thrombus) 06/2014 - 12/2008
3	Hemophilia B (Haemophilia B) 07/2022 - 01/2018
3	Respiratory Tract Infections (Respiratory Tract Infection) 02/2022 - 01/2021
3	Essential Thrombocythemia 09/2021 - 10/2004
3	Leukemia 06/2010 - 04/2006
2	Hematologic Diseases (Blood Diseases) 07/2022 - 01/2020
2	Fever (Fevers) 07/2022 - 12/2014
2	Urinary Tract Infections (Urinary Tract Infection) 01/2022 - 01/2021
2	Polycythemia Vera 09/2021 - 10/2004
2	Infections 01/2015 - 01/2006
2	Ecchymosis 09/2014 - 07/2014
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2010 - 02/2008
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2010 - 10/2004
2	Hypoxia (Hypoxemia) 10/2008 - 08/2006
2	Hematologic Neoplasms (Hematological Malignancy) 05/2007 - 04/2002
1	Hematuria 01/2021
1	COVID-19 11/2020
1	Joint Diseases (Joint Disease) 01/2020
1	Hypertriglyceridemia 01/2020
1	Thrombasthenia (Glanzmann Thrombasthenia) 01/2020
1	Hypoprothrombinemias (Prothrombin Deficiency) 02/2016
1	Undifferentiated Connective Tissue Diseases 02/2016
1	Menorrhagia 02/2016
1	Inflammation (Inflammations) 01/2016

Drug/Important Bio-Agent (IBA)

72	Inosine Triphosphate (ITP)IBA 01/2022 - 05/2004
16	Factor VIII (Coagulation Factor VIII)IBA 11/2022 - 09/2010
6	AntibodiesIBA 07/2022 - 07/2005
6	CytokinesIBA 11/2017 - 08/2006
5	Proteins (Proteins, Gene)FDA Link 07/2022 - 04/2002
5	Thrombopoietin (c-mpl Ligand)IBA 01/2017 - 10/2004
5	Messenger RNA (mRNA)IBA 07/2011 - 04/2002
4	GlucocorticoidsIBA 07/2022 - 01/2014
4	Prothrombin (Factor II)IBA 01/2021 - 07/2014
4	AutoantibodiesIBA 12/2019 - 01/2008
3	Heme (Haem)IBA 05/2022 - 05/2019
3	InterferonsIBA 09/2021 - 09/2007
3	Blood Coagulation Factors (Coagulation Factor)IBA 01/2021 - 02/2016
3	Rituximab (Mabthera)FDA Link 12/2014 - 01/2008
2	Factor IX (Coagulation Factor IX)FDA LinkGeneric 07/2022 - 05/2021
2	eltrombopag FDA Link 01/2022 - 01/2017
2	hetrombopagIBA 01/2022 - 01/2021
2	Thrombopoietin ReceptorsIBA 01/2021 - 01/2017
2	Pharmaceutical PreparationsIBA 07/2020 - 03/2011
2	ChemokinesIBA 07/2017 - 06/2010
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2017 - 01/2016
2	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 02/2016 - 07/2014
2	Therapeutic UsesIBA 04/2015 - 05/2012
2	Interleukin-18 (Interleukin 18)IBA 09/2014 - 08/2014
2	MicroRNAs (MicroRNA)IBA 09/2014 - 06/2010
2	Interleukin-4 (Interleukin 4)IBA 01/2010 - 09/2007
2	LigandsIBA 01/2009 - 04/2006
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2008 - 05/2007
2	AntigensIBA 08/2006 - 07/2005
2	LeptinIBA 08/2006 - 05/2004
1	6-pyruvoyltetrahydropterin synthase (PTPS)IBA 11/2022
1	Transaminases (Aminotransferases)IBA 07/2022
1	Monoclonal AntibodiesIBA 02/2022
1	emicizumabIBA 02/2022
1	romiplostim FDA Link 01/2022
1	Hemostatics (Antihemorrhagics)IBA 01/2021
1	Factor VII (Proconvertin)IBA 01/2021
1	IsoantibodiesIBA 01/2021
1	Triglycerides (Triacylglycerol)IBA 01/2020
1	recombinant factor VIII SQIBA 01/2020
1	recombinant factor VIII N8IBA 01/2020
1	AlbuminsIBA 01/2020
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 01/2020
1	IntegrinsIBA 01/2020
1	EpitopesIBA 12/2019
1	human F8 protein FDA Link 05/2019
1	Complementary DNA (cDNA)IBA 01/2018
1	Chemokine CXCL16IBA 11/2017
1	Interleukin-17 (Interleukin 17)IBA 07/2017
1	sugar formulated recombinant FVIIIIBA 04/2017
1	Sucrose (Saccharose)IBA 04/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2017
1	Amino Acids FDA Link 01/2017
1	CD40 Ligand (CD40L)IBA 01/2017
1	Long Noncoding RNAIBA 11/2016
1	Danazol (Azol)FDA LinkGeneric 11/2016
1	Methylprednisolone FDA LinkGeneric 02/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2016
1	EnzymesIBA 01/2016
1	LipidsIBA 01/2016
1	UbiquitinIBA 01/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016

Therapy/Procedure

19	Therapeutics 07/2022 - 01/2004
4	Splenectomy 03/2017 - 11/2005
2	Injections 11/2022 - 09/2021
2	Aftercare (After-Treatment) 02/2016 - 09/2014
1	Intravenous Infusions 07/2022
1	Drug Tapering 01/2022
1	Platelet Transfusion (Blood Platelet Transfusions) 01/2017